Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06368648 · ClinicalTrials.gov registry record

CoMind Early Feasibility Study

A clinical trial of Stroke and Traumatic Brain Injury, sponsored by CoMind Technologies Limited.

Recruiting
Registry status
581
Enrollment target
14
Study locations

NCT06368648 is a study of Stroke and Traumatic Brain Injury that is actively recruiting participants, run by CoMind Technologies Limited. The registered enrollment target is 581 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 14 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06368648, a study of Stroke and Traumatic Brain Injury, is actively recruiting participants, sponsored by CoMind Technologies Limited.

RECRUITING
Registry status
581 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pressure or ICP). Monitoring and managing ICP is an important part of care for patients with conditions such as Traumatic Brain Injury (TBI). However, the current way of measuring ICP requires surgery to drill a hole into the skull, and therefore can introduce additional risks such as infections and pain. Recent research has shown it may be possible to measure ICP without needing surgery. This technology is in development, but large amounts of data is required to build these new devices. Through collecting a large database of information from patients who have both the routine surgical device and the research device applied to their head, the research team will work to develop and test an effective and potentially safer way of monitoring patient ICP.

Conditions Studied

Stroke Traumatic Brain Injury Intracerebral Hemorrhage Hydrocephalus Encephalopathy Encephalitis Intracranial Pressure Intracranial Pressure Changes Autoregulation

Study Locations (14)

New York

  • Albany Medical College - Albany
  • Stony Brook University Hospital - Stony Brook

California

  • UC Davis Medical Center - Sacramento

Delaware

  • Christiana Care - Wilmington

District of Columbia

  • Medstar Health - Washington D.C.

Florida

  • Jackson Memorial Hospital - Miami

Kansas

  • The University of Kansas Medical Center - Kansas City

Missouri

  • Washington University Medical Center - St Louis

North Carolina

  • WakeMed - Raleigh

Trial Details

FieldValue
Enrollment Target 581 participants
Start Date 2024-11-27
Est. Completion 2026-11

Sponsor

CoMind Technologies Limited

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06368648

The ClinicalTrials.gov registry entry for NCT06368648 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 581 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The listed sponsor is CoMind Technologies Limited, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT06368648 reports 14 study locations spanning 13 distinct geographic areas - top geographies include New York, California, Delaware.

Frequently Asked Questions

What is clinical trial NCT06368648 about?

NCT06368648 is a clinical study titled "CoMind Early Feasibility Study". The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial press...

What is the current status of trial NCT06368648?

This trial is currently recruiting. The enrollment target is 581 participants. The study started on 2024-11-27. Estimated completion is 2026-11.

What conditions does trial NCT06368648 study?

This clinical trial studies the following conditions: Stroke, Traumatic Brain Injury, Intracerebral Hemorrhage, Hydrocephalus, Encephalopathy.

Who is sponsoring clinical trial NCT06368648?

This trial is sponsored by CoMind Technologies Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06368648 being conducted?

This trial has 14 study locations across California, Delaware, District of Columbia, Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Traumatic Brain Injury

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.